611
Views
25
CrossRef citations to date
0
Altmetric
Reviews

CD133 as a target for colon cancer

, , , , &
Pages 259-267 | Published online: 03 Mar 2012

Bibliography

  • Frank NY, Schatton T, Frank MH. The therapeutic promise of the cancer stem cell concept. J Clin Invest 2010;120:41-50
  • Scopelliti A, Cammareri P, Catalano V, Therapeutic implications of cancer initiating cells. Expert Opin Biol Ther 2009;9:1005-16
  • Dick JE. Stem cell concepts renew cancer research. Blood 2008;112:4793-807
  • Taussig DC, Miraki-Moud F, Anjos-Afonso F, Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood 2008;112:568-75
  • Al-Hajj M, Wicha MS, Benito-Hernandez A, Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-8
  • Singh SK, Hawkins C, Clarke ID, Identification of human brain tumour initiating cells. Nature 2004;432:396-401
  • Collins AT, Berry PA, Hyde C, Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005;65:10946-51
  • O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007;445:106-10
  • Ricci-Vitiani L, Lombardi DG, Pilozzi E, Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445:111-15
  • Li C, Heidt DG, Dalerba P, Identification of pancreatic cancer stem cells. Cancer Res 2007;67:1030-7
  • Todaro M, Iovino F, Eterno V, Tumorigenic and metastatic activity of human thyroid cancer stem cells. Cancer Res 2010;70:8874-85
  • Todaro M, Francipane MG, Medema JP, Stassi G. Colon cancer stem cells: promise of targeted therapy. Gastroenterology 2010;138:2151-62
  • Medema JP, Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 2011;474:318-26
  • Sato T, van Es JH, Snippert HJ, Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 2011;469:415-18
  • Ricci-Vitiani L, Fabrizi E, Palio E, De Maria R. Colon cancer stem cells. J Mol Med (Berl) 2009;87:1097-104
  • Chang WW, Leblond CP. Renewal of the epithelium in the descending colon of the mouse. I. Presence of three cell populations: vacuolated-columnar, mucous and argentaffin. Am J Anat 1971;131:73-99
  • Kim SJ, Cheung S, Hellerstein MK. Isolation of nuclei from label-retaining cells and measurement of their turnover rates in rat colon. Am J Physiol Cell Physiol 2004;286:1464-73
  • Anderson EC, Hessman C, Levin TG, The role of colorectal cancer stem cells in metastatic disease and therapeutic response. Cancers (Basel) 2011;3:319-39
  • Barker N, van de Wetering M, Clevers H. The intestinal stem cell. Genes Dev 2008;22:1856-64
  • Vogelstein B, Fearon ER, Hamilton SR, Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32
  • Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67
  • Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70
  • Grady WM, Rajput A, Myeroff L, Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res 1998;58:3101-4
  • Parsons DW, Wang TL, Samuels Y, Colorectal cancer: mutations in a signalling pathway. Nature 2005;436:792
  • Miraglia S, Godfrey W, Yin AH, A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997;90:5013-21
  • Yin AH, Miraglia S, Zanjani ED, AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002-12
  • Corbeil D, Roper K, Hellwig A, The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 2000;275:5512-20
  • Roper KD, Corbeil D, Huttner WB. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol 2000;2:582-92
  • Giebel B, Corbeil D, Beckmann J, Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells. Blood 2004;104:2332-8
  • Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000;1:31-9
  • Bauer N, Fonseca AV, Florek M, New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133). Cells Tissues Organs 2008;188:127-38
  • Todaro M, Alea MP, Di Stefano AB, Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007;1:389-402
  • Dalerba P, Dylla SJ, Park IK, Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007;104:10158-63
  • Chen KL, Pan F, Jiang H, Highly enriched CD133+CD44+ stem-like cells with CD133+CD44high metastatic subset in HCT116 colon cancer cells. Clin Exp Metastasis 2011;28:751-63
  • Shmelkov SV, Butler JM, Hooper AT, CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors. J Clin Invest 2008;118:2111-20
  • Kemper K, Sprick MR, de Bree M, The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res 2010;70:719-29
  • Fargeas CA, Joester A, Missol-Kolka E, Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis. J Cell Sci 2004;117:4301-11
  • Artells R, Moreno I, Diaz T, Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients. Eur J Cancer 2010;46:642-9
  • Huang EH, Hynes MJ, Zhang T, Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009;69:3382-9
  • Lin L, Fuchs J, Li C, STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH+/CD133+ stem cell-like human colon cancer cells. Biochem Biophys Res Commun 2011;416:246-51
  • Pohl A, El-Khoueiry A, Yang D, Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy. Pharmacogenomics J 2012; published online10 January 2012; doi: 10.1038/tpj.2011.61
  • Pilati P, Mocellin S, Bertazza L, Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis. Ann Surg Oncol 2012;19:402-8
  • Kemper K, Rodermond H, Colak S, Targeting colorectal cancer stem cells with inducible caspase-9. Apoptosis 2012; published online 06 January 2012; doi: 10.1007/s10495-011-0692-z

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.